Tobramycin/Edetate Calcium sodium

妥布霉素/依地酸钙钠

Report date: 2024/03/20 20:04:39

Base Information

Drug NameTobramycin/Edetate Calcium sodium
Drug Alias NameTobramycin + Sodium calcium edetate combination therapySodium calcium edetate/Tobramycin combination therapy - Respirion PharmaceuticalsRespirionTobramycin + Calcium EDTATobramycin + Calcium EDTA combination therapy +[7] 
ClassificationSmall molecules
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsCystic FibrosisRespiratory Tract InfectionsPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsYes TobramycinEdetate Calcium Disodium
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRespirion Pharmaceuticals Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRespirion Pharmaceuticals Pty LtdTelethon Kids Institute
Inactive CompaniesN/A
Active IndicationsCystic FibrosisRespiratory Tract InfectionsPseudomonas Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A